Last 44 quarters of trend data · Healthcare · Oncology Biotech
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -3.85 | — | — | — | — | — | 3.27 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | — | — | — | — | — | — | — | — | — | 46.89 | 69.74 | 20.04 | 17.82 | 26.28 | 24.95 | 54.48 | 28.69 | 41.61 | 63.57 | 130.75 | 456.26 |
| — | — | — | — | — | — | — | — | — | +78.4% | +179.6% | -63.2% | -37.9% | -36.8% | -60.8% | -58.3% | -93.7% | -86.2% | -80.1% | -77.3% | — | |
| P/B Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 4.79 | 7.32 | 8.45 | 15.71 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -32.0% | +28.2% | +87.2% | -10.7% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 5.00 | — | — | — | — | 54.70 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | 49.14 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | 51.42 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| — | — | — | — | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | |
| Operating Margin | — | — | — | — | — | — | — | — | -36.8% | -742.2% | -742.2% | -1099.3% | -1099.3% | -1541.0% | -1541.0% | -2434.2% | -2434.2% | -3078.1% | -3078.1% | -3104.1% | -5444.8% |
| — | — | — | — | — | — | — | — | +96.7% | +51.8% | +51.8% | +54.8% | +54.8% | +49.9% | +49.9% | +21.6% | +55.3% | +47.9% | +40.3% | +70.0% | — | |
| Net Margin | — | — | — | — | — | — | — | — | 213.2% | -726.2% | -726.2% | -948.2% | -948.2% | -1453.7% | -1453.7% | -2191.1% | -2191.1% | -2735.1% | -2735.1% | -2814.5% | -5451.0% |
| — | — | — | — | — | — | — | — | +122.5% | +50.0% | +50.0% | +56.7% | +56.7% | +46.8% | +46.8% | +22.1% | +59.8% | +52.1% | +45.6% | +71.2% | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -169.5% | -78.8% | -56.6% | -31.7% | -37.9% |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -347.2% | -172.1% | -178.9% | -3.2% | +28.9% | |
| ROA | -26.5% | -5.1% | -9.7% | -7.7% | -5.1% | -5.3% | 12.5% | -5.0% | -7.7% | -17.4% | -15.9% | -16.7% | -14.4% | -19.3% | -16.1% | -16.0% | -13.4% | -14.5% | -12.7% | -10.6% | -20.3% |
| — | +3.0% | -177.7% | -53.1% | +34.1% | +69.5% | +178.9% | +69.9% | +46.4% | +10.2% | +1.2% | -4.6% | -7.1% | -33.4% | -26.5% | -51.4% | +33.8% | +32.6% | +19.9% | +53.0% | +39.9% | |
| ROIC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.45 | 0.45 | 0.17 | 0.09 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +700.9% | +918.7% | +263.8% | -52.0% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | 1.31 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.54 | 0.70 | 1.09 | 1.54 | 1.89 | 2.19 | 2.49 | 2.60 | 2.60 | 1.82 | 1.82 | 2.31 | 2.31 | 3.78 | 3.78 | 5.24 | 5.24 | 5.02 | 5.02 | 4.96 | 5.10 |
| — | -68.2% | -56.1% | -40.7% | -27.0% | +20.3% | +36.6% | +12.1% | +12.1% | -51.8% | -51.8% | -55.8% | -55.8% | -24.6% | -24.6% | +5.7% | +2.7% | +4.1% | -32.9% | -39.8% | +83.2% | |
| Quick Ratio | 1.54 | 0.70 | 1.09 | 1.54 | 1.89 | 2.19 | 2.49 | 2.60 | 2.60 | 1.82 | 1.82 | 2.31 | 2.31 | 3.78 | 3.78 | 5.24 | 5.24 | 5.02 | 5.02 | 4.96 | 5.10 |
| — | -68.2% | -56.1% | -40.7% | -27.0% | +20.3% | +36.6% | +12.1% | +12.1% | -51.8% | -51.8% | -55.8% | -55.8% | -24.6% | -24.6% | +5.7% | +2.7% | +4.1% | -32.9% | -39.8% | +83.2% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -499.62 | -876.75 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 44 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BYSI stock.
BeyondSpring Inc.'s current P/E is -3.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking BeyondSpring Inc.'s business trajectory between earnings reports.